Literature DB >> 23133189

Advances in the management of gastric cancer.

Manas Kumar Roy1, Sagar Sadhu, Sanjay Kumar Dubey.   

Abstract

Gastric cancer is a common malignancy in our country and patients continue to present at an advanced stage. Following confirmation of diagnosis, CT scan, endoscopic ultrasound and laparoscopy are the essential staging modalities. Radical gastrectomy remains the initial treatment of choice. Although controversy persists about the extent of lymph node dissection, there is a general consensus in performing D2 dissection but with preservation of pancreas and spleen. Patients who have high risk of relapse are treated with postoperative chemoradiotherapy. The regimen of preoperative chemotherapy followed by gastrectomy and postoperative chemotherapy has also become important in recent years. Both these chemotherapeutic options confer survival advantage and patients need to be appraised about various treatment strategies at the very outset.

Entities:  

Keywords:  Adjuvant therapy; Gastric cancer; Surgery

Year:  2010        PMID: 23133189      PMCID: PMC3452751          DOI: 10.1007/s12262-009-0092-6

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  57 in total

1.  Stomach cancer incidence in the world.

Authors:  S Yamamoto
Journal:  Jpn J Clin Oncol       Date:  2001-09       Impact factor: 3.019

2.  One thousand consecutive gastrectomies without operative mortality.

Authors:  T Sano; H Katai; M Sasako; K Maruyama
Journal:  Br J Surg       Date:  2002-01       Impact factor: 6.939

3.  Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients.

Authors:  M S Karpeh; L Leon; D Klimstra; M F Brennan
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

4.  Progress in gastric cancer surgery in Japan and its limits of radicality.

Authors:  K Maruyama; K Okabayashi; T Kinoshita
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

5.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

6.  New method to evaluate the therapeutic value of lymph node dissection for gastric cancer.

Authors:  M Sasako; P McCulloch; T Kinoshita; K Maruyama
Journal:  Br J Surg       Date:  1995-03       Impact factor: 6.939

7.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

8.  Epidemiological study on Helicobacter pylori infection and extragastroduodenal disorders in Polish population.

Authors:  W Bielański
Journal:  J Physiol Pharmacol       Date:  1999-12       Impact factor: 3.011

9.  New aspects in the surgical treatment of gastric carcinoma--a comparative study of 1636 patients operated on between 1969 and 1982.

Authors:  F P Gall; P Hermanek
Journal:  Eur J Surg Oncol       Date:  1985-09       Impact factor: 4.424

10.  End results of simultaneous pancreatectomy, splenectomy and total gastrectomy for patients with gastric carcinoma.

Authors:  E Otsuji; T Yamaguchi; K Sawai; K Okamoto; T Takahashi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  2 in total

1.  Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.

Authors:  Giuseppe Verlato; Simone Giacopuzzi; Maria Bencivenga; Paolo Morgagni; Giovanni De Manzoni
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 2.  Gastric cancer: Current status of lymph node dissection.

Authors:  Maurizio Degiuli; Giovanni De Manzoni; Alberto Di Leo; Domenico D'Ugo; Erica Galasso; Daniele Marrelli; Roberto Petrioli; Karol Polom; Franco Roviello; Francesco Santullo; Mario Morino
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.